Showing results (31-40 of 82) with videos related to
Sort By:
Pageof 9
Cancer Treatment Reports|April 1, 1984
Abnormal deoxyuridine suppression as a rapid predictor for antimetabolite chemosensitivity: correlation with in vitro tests of growth inhibitionJ B Block, R T Chlebowski, M F Dietrich, et al.Cancer Research|November 1, 1985
Modulation of cytotoxicity of menadione sodium bisulfite versus leukemia L1210 by the acid-soluble thiol poolS A Akman, M Dietrich, R Chlebowski, et al.The Journal of Biological Chemistry|January 15, 1988
Biochemical and ultrastructural characterization of the 1,4-dihydropyridine receptor from rabbit skeletal muscle. Evidence for a 52,000 Da subunitA T Leung, T Imagawa, B Block, et al.The American Journal of Psychiatry|June 1, 1984
The lithium loading dose method in a clinical settingG A Fava, G Molnar, B Block, et al.Archives of Otolaryngology--Head & Neck Surgery|January 20, 2010
In vitro effects of acid and pepsin on mouse middle ear epithelial cell viability and MUC5B gene expressionBradley B Block, Elaine Kuo, Habib G Zalzal, et al.The Journal of Clinical Investigation|June 1, 1972
Impaired lymphocyte transformation in intestinal lymphangiectasia: evidence for at least two functionally distinct lymphocyte populations in manP L Weiden, R M Blaese, W Strober, et al.Cancer|August 15, 1983
Doxorubicin and CCNU with or without vincristine in patients with advanced refractory breast cancer. A randomized trialR T Chlebowski, R Pugh, J M Weiner, et al.Klinische Wochenschrift|July 15, 1987
[Low-dose alpha-interferon treatment of hairy cell leukemia]P von Wussow, M Freund, B Block, et al.Cancer Treatment Reports|March 1, 1984
Doxorubicin (75 mg/m2) for hepatocellular carcinoma: clinical and pharmacokinetic resultsR T Chlebowski, A Brzechwa-Adjukiewicz, A Cowden, et al.Cytotherapy|January 22, 2011
Dermatan sulfate and bone marrow mononuclear cells used as a new therapeutic strategy after arterial injury in miceJuliana A P Godoy, Daniel B Block, Douglas M Tollefsen, et al.Pageof 9